Quantify effets of antiviral drugs on mtDNA content to limit HIV/HCV complications.
Determine your leads' impact on mitochondrial respiration, autophagy and/or dynamics, and their modulatory pathways.
Optimize leads and select disease-modifying drugs using patient derived cell models.
Mitochondrial dysfunctions are crucial in metabolic diseases. Use one of our several experimental
in vitro models available.
Use our expertise to understand your drugs' MOA and refine its indication.
Use our technologies in a fast-fail strategy to reduce your development costs.